LAMPERTICO, PIETRO
LAMPERTICO, PIETRO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
HDV RNA Assays: Performance characteristics, clinical utility and challenges
2023 H. Wedemeyer, M. Leus, T. R Battersby, J. Glenn, E. Gordien, S. Kamili, H. Kapoor, H. H Kessler, O. Lenz, M. Lütgehetmann, T. Mixson-Hayden, C. O Simon, M. Thomson, G. Westman, V. Miller, N. Terrault, P. Lampertico
No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta
2023 J. Hollnberger, Y. Liu, S. Xu, S. Chang, R. Martin, S. Manhas, T. Aeschbacher, B. Han, T. Yazdi, L. May, D. Han, A. Shornikov, J. Flaherty, D. Manuilov, V. Suri, T. Asselah, P. Lampertico, H. Wedemeyer, S. Aleman, C. Richards, R. Mateo, E. Maiorova, T. Cihlar, H. Mo, S. Urban
Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection
2023 H. Janssen, J. Hou, T. Asselah, H. Chan, F. Zoulim, Y. Tanaka, E. Janczewska, R. Nahass, S. Bourgeois, M. Buti, P. Lampertico, O. Lenz, T. Verbinnen, Vandenbosschej, W. Talloen, R. Kalmeijer, M. Beumont, M. Biermer, U. Shukla
Hepatocellular carcinoma surveillance - utilization, barriers and the impact of changing aetiology
2023 D. Huang, A. Singal, F. Kanwal, P. Lampertico, M. Buti, C. Sirlin, M. Nguyen, R. Loomba
Induced myocardial ischemia in candidates to liver transplantation without evidence of heart disease
2023 L. Mircoli, N. Bacà, B. Antonelli, L. Caccamo, E. Cattaneo, F. Colombo, C. Dibenedetto, L. Diehl, M.F. Donato, A. Faggiano, M.A. Iavarone, P. Lampertico, C. Marenghi, F. Polli, E. Quarenghi, F.B. Sozzi, C. Spaziani, G. Tosetti, C. Valsecchi, P. Vicardi, M. Vicenzi, A. Zefelippo, M. Ruscica, S. Carugo
Stesura di progetto internazionale di screening, vaccinazione e cura contro l'epatite C - Multi-country Viral Hepatitis COMmunity Screening, Vaccination, and Care (VH-COMSAVAC): Project outline
2023 A.M. Pezzullo, C.A. Picchio, L. Villani, D. Pascucci, R. Pastorino, M. Di Pumpo, A. Taha, L. Van Selm, D. Boudou, D. Fortin, G. Kalamitsis, M. Colombo, G. Colucci, P. Lampertico, A.G. De Belvis, C. La Vecchia, S. Boccia, J.V. Lazarus
The Impact of Antiviral Treatment of Hepatitis B Virus after Kidney Transplant and the Latest Insights
2023 F. Fabrizi, M. Donato, F. Tripodi, A. Regalia, P. Lampertico, G. Castellano
Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug Classes
2023 M. G Peters, M. Yuen, N. Terrault, J. Fry, P. Lampertico, E. Gane, C. Hwang, L. M Stamm, M. Leus, M. K Maini, P. Mendez, I. Lonjon-Domanec, T. Berg, S. Wang, P. Mishra, E. Donaldson, S. Buchholz, V. Miller, O. Lenz
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination
2023 G. Brancaccio, B. Coco, A. Nardi, M. Quaranta, M. Tosti, L. Ferrigno, I. Cacciola, V. Messina, L. Chessa, F. Morisco, M. Milella, F. Barbaro, A. Ciancio, F. Russo, Coppolan, P. Blanc, E. Claar, G. Verucchi, M. Puoti, A. Zignego, L. Chemello, S. Madonia, S. Fagiuoli, A. Marzano, C. Ferrari, P. Lampertico, V. Di Marco, A. Craxì, T. Santantonio, G. Raimondo, M. Brunetto, G. Gaeta, L. Kondili, P. Luisa, C. Carmine, P. Federica, R. Mariarosaria, P. Carmen, B. Irene Francesca, C. Valentina, T. Xhimi, S. Caterina, P. Piera, D. Elisabetta, R. Valerio, B. Lorenzo, I. Dontella, M. Monica, B. Maria Grazia, C. Luisa, T. Pierluigi, F. Ezio, C. Antonio, F. Alberto, N. Gerardo, R. Alba, V. Mauro, F. Francesco Giuseppe, C. Fabio, M. Giulia, S. Stefania, T. Carlo, C. Chiara, F. Alessandro, D. Marcello, G. Alessia, A. Marco, L. Pasqualina De, Z. Serena, C. Anna, P. Fabio, S. Ilaria, S. Simona, M. Antonio, C. Luciana, M. Marco, M. Cesare, M. Aldo, D. Francesca Maria, D. Gianpiero, L. Anna, N. Grazia Anna, P. Teresa, A. Alessio
Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort
2023 L. A Kondili, M. Giovanna Quaranta, L. Cavalletto, V. Calvaruso, L. Ferrigno, R. D'Ambrosio, I. Simonelli, G. Brancaccio, G. Raimondo, M. R Brunetto, A. Linda Zignego, C. Coppola, A. Iannone, E. Biliotti, G. Verucchi, M. Massari, A. Licata, F. Barbaro, M. Persico, F. Paolo Russo, F. Morisco, M. Pompili, M. Viganò, M. Puoti, T. Santantonio, E. Villa, A. Craxì, L. Chemello, V. Panetta, G. Battista Gaeta, R. Filomia, B. Coco, M. Monti, D. Caterina Amoruso, S. Madonia, D. Ieluzzi, G. Taliani, L. Badia, G. Marco Migliorino, A. Giorgini, M. Masarone, P. Blanc, V. Cossiga, M. De Siena, X. Tata, M. Grazia Rumi, L. Chessa, P. Lampertico, C. Ferrari, I. Gentile, G. Parruti, L. Baiocchi, A. Ciancio, P. Invernizzi, A. Federico, C. Torti, G. Morsica, P. Andreone, A. Aghemo, P. Popoli, S. Vella
Metabolic dysfunction outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct‐acting antivirals
2023 S. Pelusi, C. Bianco, M. Colombo, G. Cologni, P. Del Poggio, N. Pugliese, D. Prati, M. Graciella Pigozzi, R. D'Ambrosio, P. Lampertico, S. Fagiuoli, L.V.C. Valenti
Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022
2023 P. Lampertico, E. Degasperi, L. Sandmann, H. Wedemeyer, C. Yurdaydin, D. Roulot, F. Zoulim, F.A. Caruntu, H. Kefalakes, J. Lucifora, K. Agarwal, L. Castera, M. Buti, M. Rizzetto, M. Cornberg, M. Dandri, M. Brunetto, N. Reau, R. Gish, S. Hamid, S. Aleman, S. Urban, T. Asselah, T. Berg, V. de Ledinghen
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro
2023 M. Rossi, A. Vecchi, C. Tiezzi, V. Barili, P. Fisicaro, A. Penna, I. Montali, S. Daffis, S. Fletcher, A. Gaggar, J. Medley, M. Graupe, L. Lad, A. Loglio, R. Soffredini, M. Borghi, T. Pollicino, C. Musolino, A. Alfieri, F. Brillo, D. Laccabue, M. Massari, C. Boarini, G. Abbati, G. Pedrazzi, G. Missale, P. Lampertico, C. Ferrari, C. Boni
A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In Cirrhotics
2023 M.P. Anolli, E. Degasperi, L. Allweiss, A. Sangiovanni, M. Maggioni, C. Scholtes, V. Oberhardt, C. Neumann-Haefelin, M. Dandri, F. Zoulim, P. Lampertico
Carvedilol to reduce the risk of decompensation in patients with compensated cirrhosis: Is it really needed in patients with cured HCV or suppressed HBV?
2023 G. Tosetti, E. Degasperi, E. Farina, M. Primignani, P. Lampertico
Bulevirtide‐based treatment strategies for chronic hepatitis delta: A review
2023 E. Degasperi, M.P. Anolli, P. Lampertico
Hepatitis Delta: Ready for primetime?
2023 B. Maasoumy, P. Lampertico
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B
2023 I. Montali, C. Ceccatelli Berti, M. Morselli, G. Acerbi, V. Barili, G. Pedrazzi, B. Montanini, C. Boni, A. Alfieri, M. Pesci, A. Loglio, E. Degasperi, M. Borghi, R. Perbellini, A. Penna, D. Laccabue, M. Rossi, A. Vecchi, C. Tiezzi, V. Reverberi, C. Boarini, G. Abbati, M. Massari, P. Lampertico, G. Missale, C. Ferrari, P. Fisicaro
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D
2023 H. Wedemeyer, S. Aleman, M. Brunetto, A. Blank, P. Andreone, P. Bogomolov, V. Chulanov, N. Mamonova, N. Geyvandova, V. Morozov, O. Sagalova, T. Stepanova, A. Berger, D. Manuilov, V. Suri, Q. An, B. Da, J. Flaherty, A. Osinusi, Y. Liu, U. Merle, J. Schulze Zur Wiesch, S. Zeuzem, S. Ciesek, M. Cornberg, P. Lampertico
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference
2023 M.G. Ghany, M. Buti, P. Lampertico, H.M. Lee